Deutsch
Deutschland
Anmelden
Tipp von eurobuch.com
Ähnliche Bücher
Weitere, andere Bücher, die diesem Buch sehr ähnlich sein könnten:
Buch verkaufen
Anbieter, die das Buch mit der ISBN 9781402069864 ankaufen:
Suchtools
Buchtipps
Aktuelles
FILTER
- 0 Ergebnisse
Kleinster Preis: 8,50 €, größter Preis: 210,45 €, Mittelwert: 152,00 €
IBD 2007 - Achievements in Research and Clinical Practice - N. Tözün
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)
N. Tözün:
IBD 2007 - Achievements in Research and Clinical Practice - neues Buch

2007, ISBN: 9781402069864

[ED: Buch], [PU: Springer-Verlag GmbH], Neuware - There is no single truth regarding the recognition and management of IBD. In this regards the old dictum there is no disease but the patient should be the golden rule. Nowadays, more complicated Crohn's disease cases at relatively young ages are not unusual. Various clinical and extraintestinal manifestations have been seen rarely until now. The evolution of the therapeutic armamentarium is now a double-edged sword since more drugs may mean more side-effects, less compliance and a more critical attitude of health authorities towards the cost of treatment . Education of the patient and the family, creation of empathy and a positive rapport with the patient and a careful analysis of confounding/contributing factors to the disease behaviour are essential elements of optimal therapy of IBD patients. This book contains the proceedings of Falk Symposium 159, entitled IBD 2007 -- Achievements in Research and Clinical Practice, held in Istanbul, Turkey, on May 4--5, 2007, where opinion leaders with worldwide reputations discuss IBD and related issues in a less well-known part of the world with respect to prevalence, disease behaviour and patient characteristics, as well as the difficulties faced in differential diagnosis and management. The recent increase in the incidence of inflammatory bowel disease (IBD) and especially of Crohn's disease is not a myth. Much speculation has been made regarding the effect of some known and some unidentified risk factors which might account for this steady rise but one cannot deny the contribution of the faster and more effective spread of information between scientists and the development of more sophisticated diagnostic techniques which enable us to categorize the disease in a more comprehensive way. Inflammatory bowel diseases come to the attention of the physician with different faces and different scenarios and even the same patient may show up with different patterns in various regions of the world. When the clinical course seems not to be going well despite appropriate medications, a search for unexpected factors such as concomitant IBS, intercurrent infections and drug toxicity such as aminosalicylates should be considered. The impact of parasites, notably amoeba or giardia, and bacterial or viral infections deserve special attention in some parts of the world such as the eastern Mediterranean, North Africa, Middle East and Asia. There is no single truth regarding the recognition and management of IBD. In this regards the old dictum there is no disease but the patient should be the golden rule. Nowadays, more complicated Crohn's disease cases at relatively young ages are not unusual. Various clinical and extraintestinal manifestations have been seen rarely until now. The evolution of the therapeutic armamentarium is now a double-edged sword since more drugs may mean more side-effects, less compliance and a more critical attitude of health authorities towards the cost of treatment . Education of the patient and the family, creation of empathy and a positive rapport with the patient and a careful analysis of confounding/contributing factors to the disease behaviour are essential elements of optimal therapy of IBD patients. This book contains the proceedings of Falk Symposium 159, entitled IBD 2007 -- Achievements in Research and Clinical Practice, held in Istanbul, Turkey, on May 4--5, 2007, where opinion leaders with worldwide reputations discuss IBD and related issues in a less well-known part of the world with respect to prevalence, disease behaviour and patient characteristics, as well as the difficulties faced in differential diagnosis and management. -, [SC: 0.00], Neuware, gewerbliches Angebot, 239x165x23 mm, [GW: 617g]

Neues Buch Booklooker.de
Sparbuchladen
Versandkosten:Versandkostenfrei, Versand nach Deutschland (EUR 0.00)
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
IBD 2007 - Achievements in Research and Clinical Practice - N. Tözün
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)
N. Tözün:
IBD 2007 - Achievements in Research and Clinical Practice - neues Buch

2007, ISBN: 9781402069864

[ED: Buch], [PU: Springer-Verlag GmbH], Neuware - There is no single truth regarding the recognition and management of IBD. In this regards the old dictum there is no disease but the patient should be the golden rule. Nowadays, more complicated Crohn's disease cases at relatively young ages are not unusual. Various clinical and extraintestinal manifestations have been seen rarely until now. The evolution of the therapeutic armamentarium is now a double-edged sword since more drugs may mean more side-effects, less compliance and a more critical attitude of health authorities towards the cost of treatment . Education of the patient and the family, creation of empathy and a positive rapport with the patient and a careful analysis of confounding/contributing factors to the disease behaviour are essential elements of optimal therapy of IBD patients. This book contains the proceedings of Falk Symposium 159, entitled IBD 2007 -- Achievements in Research and Clinical Practice, held in Istanbul, Turkey, on May 4--5, 2007, where opinion leaders with worldwide reputations discuss IBD and related issues in a less well-known part of the world with respect to prevalence, disease behaviour and patient characteristics, as well as the difficulties faced in differential diagnosis and management. The recent increase in the incidence of inflammatory bowel disease (IBD) and especially of Crohn's disease is not a myth. Much speculation has been made regarding the effect of some known and some unidentified risk factors which might account for this steady rise but one cannot deny the contribution of the faster and more effective spread of information between scientists and the development of more sophisticated diagnostic techniques which enable us to categorize the disease in a more comprehensive way. Inflammatory bowel diseases come to the attention of the physician with different faces and different scenarios and even the same patient may show up with different patterns in various regions of the world. When the clinical course seems not to be going well despite appropriate medications, a search for unexpected factors such as concomitant IBS, intercurrent infections and drug toxicity such as aminosalicylates should be considered. The impact of parasites, notably amoeba or giardia, and bacterial or viral infections deserve special attention in some parts of the world such as the eastern Mediterranean, North Africa, Middle East and Asia. There is no single truth regarding the recognition and management of IBD. In this regards the old dictum there is no disease but the patient should be the golden rule. Nowadays, more complicated Crohn's disease cases at relatively young ages are not unusual. Various clinical and extraintestinal manifestations have been seen rarely until now. The evolution of the therapeutic armamentarium is now a double-edged sword since more drugs may mean more side-effects, less compliance and a more critical attitude of health authorities towards the cost of treatment . Education of the patient and the family, creation of empathy and a positive rapport with the patient and a careful analysis of confounding/contributing factors to the disease behaviour are essential elements of optimal therapy of IBD patients. This book contains the proceedings of Falk Symposium 159, entitled IBD 2007 -- Achievements in Research and Clinical Practice, held in Istanbul, Turkey, on May 4--5, 2007, where opinion leaders with worldwide reputations discuss IBD and related issues in a less well-known part of the world with respect to prevalence, disease behaviour and patient characteristics, as well as the difficulties faced in differential diagnosis and management. -, [SC: 0.00]

Neues Buch Booklooker.de
Sparbuchladen
Versandkosten:Versandkostenfrei, Versand nach Deutschland (EUR 0.00)
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
IBD 2007 - Achievements in Research and Clinical Practice - Tozun, N. / Dagli, U. / Mantzaris, G.
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)
Tozun, N. / Dagli, U. / Mantzaris, G.:
IBD 2007 - Achievements in Research and Clinical Practice - gebrauchtes Buch

2007, ISBN: 9781402069864

ID: 6052418

The recent increase in the incidence of inflammatory bowel disease (IBD) and especially of Crohn's disease is not a myth. Much speculation has been made regarding the effect of some known and some unidentified risk factors which might account for this steady rise but one cannot deny the contribution of the faster and more effective spread of information between scientists and the development of more sophisticated diagnostic techniques which enable us to categorize the disease in a more comprehensive way. Inflammatory bowel diseases come to the attention of the physician with different faces and different scenarios and even the same patient may show up with different patterns in various regions of the world. When the clinical course seems not to be going well despite appropriate medications, a search for unexpected factors such as concomitant IBS, intercurrent infections and drug toxicity such as aminosalicylates should be considered. The impact of parasites, notably amoeba or giardia, and bacterial or viral infections deserve special attention in some parts of the world such as the eastern Mediterranean, North Africa, Middle East and Asia. There is no single truth regarding the recognition and management of IBD. In this regards the old dictum a oethere is no disease but the patienta should be the golden rule. Nowadays, more complicated Crohn's disease cases at relatively young ages are not unusual. Various clinical and extraintestinal manifestations have been seen rarely until now. The evolution of the therapeutic armamentarium is now a double-edged sword since a oemore drugsa may mean a oemore side-effects, less compliance and a more critical attitude of health authorities towards the cost of treatmenta . Education of the patient and the family, creation of empathy and a positive rapport with the patient and a careful analysis of confounding/contributing factors to the disease behaviour are essential elements of optimal therapy of IBD patients. This book contains the proceedings of Falk Symposium 159, entitled IBD 2007 -- Achievements in Research and Clinical Practice, held in Istanbul, Turkey, on May 4--5, 2007, where opinion leaders with worldwide reputations discuss IBD and related issues in a less well-known part of the world with respect to prevalence, disease behaviour and patient characteristics, as well as the difficulties faced in differential diagnosis and management. IBD 2007 - Achievements in Research and Clinical Practice Tozun, N. / Dagli, U. / Mantzaris, G., Springer

gebrauchtes bzw. antiquarisches Buch Betterworldbooks.com
Versandkosten: EUR 0.00
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
IBD 2007 - Achievements in Research and Clinical Practice - N. Tözün
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)
N. Tözün:
IBD 2007 - Achievements in Research and Clinical Practice - neues Buch

2007, ISBN: 9781402069864

[ED: Buch], [PU: Springer-Verlag GmbH], Neuware - There is no single truth regarding the recognition and management of IBD. In this regards the old dictum 'there is no disease but the patient' should be the golden rule. Nowadays, more complicated Crohn's disease cases at relatively young ages are not unusual. Various clinical and extraintestinal manifestations have been seen rarely until now. The evolution of the therapeutic armamentarium is now a double-edged sword since 'more drugs' may mean 'more side-effects, less compliance and a more critical attitude of health authorities towards the cost of treatment'. Education of the patient and the family, creation of empathy and a positive rapport with the patient and a careful analysis of confounding/contributing factors to the disease behaviour are essential elements of optimal therapy of IBD patients., [SC: 0.00]

Neues Buch Booklooker.de
Carl Hübscher GmbH
Versandkosten:Versandkostenfrei, Versand nach Deutschland (EUR 0.00)
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
IBD 2007 - Achievements in Research and Clinical Practice - Tözün, N. (Herausgeber); Dagli, U (Herausgeber); Mantzaris, G. (Herausgeber); Schölmerich, J. (Herausgeber)
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)
Tözün, N. (Herausgeber); Dagli, U (Herausgeber); Mantzaris, G. (Herausgeber); Schölmerich, J. (Herausgeber):
IBD 2007 - Achievements in Research and Clinical Practice - gebunden oder broschiert

2008, ISBN: 1402069863

ID: A5523419

Gebundene Ausgabe Akutmedizin, Medizin / Notfallmedizin, Notarzt, Notfallmedizin, MEDICAL / Gastroenterology, mit Schutzumschlag neu, [PU:Springer-Verlag GmbH]

Neues Buch Achtung-Buecher.de
REDIVIVUS Buchhandlung Hanausch Reinhard, 93053 Regensburg
Versandkosten:Versandkostenfrei innerhalb der BRD (EUR 0.00)
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.

Details zum Buch
IBD 2007 - Achievements in Research and Clinical Practice

There is no single truth regarding the recognition and management of IBD. In this regards the old dictum "there is no disease but the patient" should be the golden rule. Nowadays, more complicated Crohn's disease cases at relatively young ages are not unusual. Various clinical and extraintestinal manifestations have been seen rarely until now. The evolution of the therapeutic armamentarium is now a double-edged sword since "more drugs" may mean "more side-effects, less compliance and a more critical attitude of health authorities towards the cost of treatment". Education of the patient and the family, creation of empathy and a positive rapport with the patient and a careful analysis of confounding/contributing factors to the disease behaviour are essential elements of optimal therapy of IBD patients. This book contains the proceedings of Falk Symposium 159, entitled IBD 2007 -- Achievements in Research and Clinical Practice, held in Istanbul, Turkey, on May 4--5, 2007, where opinion leaders with worldwide reputations discuss IBD and related issues in a less well-known part of the world with respect to prevalence, disease behaviour and patient characteristics, as well as the difficulties faced in differential diagnosis and management.

Detailangaben zum Buch - IBD 2007 - Achievements in Research and Clinical Practice


EAN (ISBN-13): 9781402069864
ISBN (ISBN-10): 1402069863
Gebundene Ausgabe
Erscheinungsjahr: 2008
Herausgeber: Springer-Verlag GmbH
298 Seiten
Gewicht: 0,617 kg
Sprache: eng/Englisch

Buch in der Datenbank seit 04.05.2008 13:25:21
Buch zuletzt gefunden am 09.03.2017 21:32:04
ISBN/EAN: 9781402069864

ISBN - alternative Schreibweisen:
1-4020-6986-3, 978-1-4020-6986-4


< zum Archiv...
Benachbarte Bücher